4//SEC Filing
Valentine Karen 4
Accession 0001562180-20-003453
CIK 0001434418other
Filed
May 6, 8:00 PM ET
Accepted
May 7, 4:34 PM ET
Size
18.5 KB
Accession
0001562180-20-003453
Insider Transaction Report
Form 4
Valentine Karen
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2020-05-06$11.50/sh+10,099$116,139→ 10,099 total - Exercise/Conversion
Common Stock
2020-05-06$8.76/sh+2,467$21,611→ 12,566 total - Sale
Common Stock
2020-05-06$40.10/sh−12,566$503,897→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-05-05−4,744→ 109,241 totalExercise: $11.50Exp: 2028-07-18→ Common Stock (4,744 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2020-05-06−10,099→ 99,142 totalExercise: $11.50Exp: 2028-07-18→ Common Stock (10,099 underlying) - Exercise/Conversion
Common Stock
2020-05-05$11.50/sh+4,744$54,556→ 4,744 total - Sale
Common Stock
2020-05-05$40.01/sh−4,744$189,817→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2020-05-06−2,467→ 22,425 totalExercise: $8.76Exp: 2029-03-06→ Common Stock (2,467 underlying)
Footnotes (5)
- [F1]These trades were made pursuant to a Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $40.00 to $40.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $40.00 to $40.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This option was granted on July 19, 2018. The shares underlying the option are scheduled to vest in equal quarterly installments through July 16, 2022.
- [F5]This option was granted on March 7, 2019. The shares underlying the option are scheduled to vest in equal quarterly installments through March 7, 2023.
Documents
Issuer
CONSTELLATION PHARMACEUTICALS INC
CIK 0001434418
Entity typeother
Related Parties
1- filerCIK 0001437152
Filing Metadata
- Form type
- 4
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 4:34 PM ET
- Size
- 18.5 KB